Mirati Therapeutics, Inc., a commercial stage biotechnology company, announced the Journal of Clinical Oncology published in a Rapid Communication data indicating adagrasib, a potent and selective...
Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, announced the appointment of Laurie Stelzer as the Company's Chief Financial Officer (CFO) effective May 16,...
